APO Research
Talk to an analyst

APO RESEARCH · REPORT

Finasteride Preparations

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Finasteride Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchFinasteride Preparations Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Preparations Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Finasteride Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Preparations Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Preparations Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Finasteride Preparations market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Finasteride Preparations include Zhejiang Xianju Pharmaceutical, Grand Pharmaceutical, Topfond Pharmaceutical, Shanghai Shyndec Pharmaceutical, Humanwell Pharmaceutical, Zhejiang Conba Pharmaceutical, CR Double-Crane, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Finasteride Preparations market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Finasteride Preparations and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Finasteride Preparations sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Finasteride Preparations market size, projected growth trends, production technologies, key applications, and end-use industries.

Finasteride Preparations Segment by Company

Zhejiang Xianju Pharmaceutical

Grand Pharmaceutical

Topfond Pharmaceutical

Shanghai Shyndec Pharmaceutical

Humanwell Pharmaceutical

Zhejiang Conba Pharmaceutical

CR Double-Crane

Zydus

Teva

Sun Pharma

Organon

Hetero

Dr. Reddy's Laboratories

Aurobindo Pharma

Alkem

Accord Healthcare

Finasteride Preparations Segment by Type

Capsules

Tablets

Finasteride Preparations Segment by Application

Male Pattern Baldness

Benign Prostatic Hyperplasia (BPH)

Other

Finasteride Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Finasteride Preparations market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Finasteride Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Finasteride Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Finasteride Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Finasteride Preparations Industry Trends Table 2. Finasteride Preparations Industry Drivers Table 3. Finasteride Preparations Industry Opportunities and Challenges Table 4. Finasteride Preparations Industry Restraints Table 5. Global Finasteride Preparations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Finasteride Preparations Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Finasteride Preparations Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Finasteride Preparations Sales Market Share by Manufacturers Table 9. Global Finasteride Preparations Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Finasteride Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Finasteride Preparations Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Finasteride Preparations Manufacturers, Product Type & Application Table 13. Global Finasteride Preparations Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Finasteride Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Tablets Table 18. Global Finasteride Preparations Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 20. Global Finasteride Preparations Sales by Type (2027-2032) & (K Units) Table 21. Global Finasteride Preparations Sales Market Share by Type (2021-2026) Table 22. Global Finasteride Preparations Sales Market Share by Type (2027-2032) Table 23. Global Finasteride Preparations Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Finasteride Preparations Revenue by Type (2021-2026) & (K Units) Table 25. Global Finasteride Preparations Revenue by Type (2027-2032) & (K Units) Table 26. Global Finasteride Preparations Revenue Market Share by Type (2021-2026) Table 27. Global Finasteride Preparations Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Male Pattern Baldness Table 29. Major Manufacturers of Benign Prostatic Hyperplasia (BPH) Table 30. Major Manufacturers of Other Table 31. Global Finasteride Preparations Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 33. Global Finasteride Preparations Sales by Application (2027-2032) & (K Units) Table 34. Global Finasteride Preparations Sales Market Share by Application (2021-2026) Table 35. Global Finasteride Preparations Sales Market Share by Application (2027-2032) Table 36. Global Finasteride Preparations Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Finasteride Preparations Revenue by Application (2021-2026) & (K Units) Table 38. Global Finasteride Preparations Revenue by Application (2027-2032) & (K Units) Table 39. Global Finasteride Preparations Revenue Market Share by Application (2021-2026) Table 40. Global Finasteride Preparations Revenue Market Share by Application (2027-2032) Table 41. Global Finasteride Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Finasteride Preparations Sales by Region (2021-2026) & (K Units) Table 43. Global Finasteride Preparations Sales Market Share by Region (2021-2026) Table 44. Global Finasteride Preparations Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Finasteride Preparations Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 48. North America Finasteride Preparations Sales by Country (2027-2032) & (K Units) Table 49. Europe Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 51. Europe Finasteride Preparations Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Finasteride Preparations Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Finasteride Preparations Sales by Country (2027-2032) & (K Units) Table 58. Global Finasteride Preparations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Finasteride Preparations Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Finasteride Preparations Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Finasteride Preparations Revenue Market Share by Region (2021-2026) Table 62. Global Finasteride Preparations Revenue Market Share by Region (2027-2032) Table 63. Zhejiang Xianju Pharmaceutical Company Information Table 64. Zhejiang Xianju Pharmaceutical Business Overview Table 65. Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio Table 67. Zhejiang Xianju Pharmaceutical Recent Development Table 68. Grand Pharmaceutical Company Information Table 69. Grand Pharmaceutical Business Overview Table 70. Grand Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Grand Pharmaceutical Finasteride Preparations Product Portfolio Table 72. Grand Pharmaceutical Recent Development Table 73. Topfond Pharmaceutical Company Information Table 74. Topfond Pharmaceutical Business Overview Table 75. Topfond Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Topfond Pharmaceutical Finasteride Preparations Product Portfolio Table 77. Topfond Pharmaceutical Recent Development Table 78. Shanghai Shyndec Pharmaceutical Company Information Table 79. Shanghai Shyndec Pharmaceutical Business Overview Table 80. Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio Table 82. Shanghai Shyndec Pharmaceutical Recent Development Table 83. Humanwell Pharmaceutical Company Information Table 84. Humanwell Pharmaceutical Business Overview Table 85. Humanwell Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Humanwell Pharmaceutical Finasteride Preparations Product Portfolio Table 87. Humanwell Pharmaceutical Recent Development Table 88. Zhejiang Conba Pharmaceutical Company Information Table 89. Zhejiang Conba Pharmaceutical Business Overview Table 90. Zhejiang Conba Pharmaceutical Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio Table 92. Zhejiang Conba Pharmaceutical Recent Development Table 93. CR Double-Crane Company Information Table 94. CR Double-Crane Business Overview Table 95. CR Double-Crane Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. CR Double-Crane Finasteride Preparations Product Portfolio Table 97. CR Double-Crane Recent Development Table 98. Zydus Company Information Table 99. Zydus Business Overview Table 100. Zydus Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zydus Finasteride Preparations Product Portfolio Table 102. Zydus Recent Development Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Finasteride Preparations Product Portfolio Table 107. Teva Recent Development Table 108. Sun Pharma Company Information Table 109. Sun Pharma Business Overview Table 110. Sun Pharma Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sun Pharma Finasteride Preparations Product Portfolio Table 112. Sun Pharma Recent Development Table 113. Organon Company Information Table 114. Organon Business Overview Table 115. Organon Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Organon Finasteride Preparations Product Portfolio Table 117. Organon Recent Development Table 118. Hetero Company Information Table 119. Hetero Business Overview Table 120. Hetero Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hetero Finasteride Preparations Product Portfolio Table 122. Hetero Recent Development Table 123. Dr. Reddy's Laboratories Company Information Table 124. Dr. Reddy's Laboratories Business Overview Table 125. Dr. Reddy's Laboratories Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio Table 127. Dr. Reddy's Laboratories Recent Development Table 128. Aurobindo Pharma Company Information Table 129. Aurobindo Pharma Business Overview Table 130. Aurobindo Pharma Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Aurobindo Pharma Finasteride Preparations Product Portfolio Table 132. Aurobindo Pharma Recent Development Table 133. Alkem Company Information Table 134. Alkem Business Overview Table 135. Alkem Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Alkem Finasteride Preparations Product Portfolio Table 137. Alkem Recent Development Table 138. Accord Healthcare Company Information Table 139. Accord Healthcare Business Overview Table 140. Accord Healthcare Finasteride Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Accord Healthcare Finasteride Preparations Product Portfolio Table 142. Accord Healthcare Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Finasteride Preparations Distributors List Table 146. Finasteride Preparations Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Finasteride Preparations Product Image Figure 2. Global Finasteride Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Finasteride Preparations Sales (2021-2032) & (K Units) Figure 5. Global Finasteride Preparations Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Finasteride Preparations Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Tablets Image Figure 10. Global Finasteride Preparations Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Finasteride Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Finasteride Preparations Sales Market Share by Type (2021-2032) Figure 13. Global Finasteride Preparations Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Finasteride Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Finasteride Preparations Revenue Market Share by Type (2021-2032) Figure 16. Male Pattern Baldness Image Figure 17. Benign Prostatic Hyperplasia (BPH) Image Figure 18. Other Image Figure 19. Global Finasteride Preparations Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Finasteride Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Finasteride Preparations Sales Market Share by Application (2021-2032) Figure 22. Global Finasteride Preparations Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Finasteride Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Finasteride Preparations Revenue Market Share by Application (2021-2032) Figure 25. North America Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Finasteride Preparations Sales Market Share by Country (2021-2032) Figure 27. U.S. Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Finasteride Preparations Sales Market Share by Country (2021-2032) Figure 32. Germany Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Finasteride Preparations Sales Market Share by Country (2021-2032) Figure 39. China Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Finasteride Preparations Sales Market Share by Country (2021-2032) Figure 47. Brazil Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Finasteride Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Finasteride Preparations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Finasteride Preparations Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Finasteride Preparations Revenue (2021-2032) & (US$ Million) Figure 58. North America Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Finasteride Preparations Revenue (2021-2032) & (US$ Million) Figure 60. Europe Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Finasteride Preparations Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Finasteride Preparations Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Finasteride Preparations Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Finasteride Preparations Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Male Pattern Baldness
  • Benign Prostatic Hyperplasia (BPH)
  • Other
Companies covered
  • Zhejiang Xianju Pharmaceutical
  • Grand Pharmaceutical
  • Topfond Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Humanwell Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • CR Double-Crane
  • Zydus
  • Teva
  • Sun Pharma
  • Organon
  • Hetero
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • Alkem
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Finasteride Preparations Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Finasteride Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Finasteride Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Finasteride Preparations Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Finasteride Preparations Market Dynamics
  1. 2.1 Finasteride Preparations Industry Trends
  2. 2.2 Finasteride Preparations Industry Drivers
  3. 2.3 Finasteride Preparations Industry Opportunities and Challenges
  4. 2.4 Finasteride Preparations Industry Restraints
3 Finasteride Preparations Market by Manufacturers
  1. 3.1 Global Finasteride Preparations Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Finasteride Preparations Sales by Manufacturers (2021-2026)
  3. 3.3 Global Finasteride Preparations Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Finasteride Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Finasteride Preparations Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Finasteride Preparations Manufacturers, Product Type & Application
  7. 3.7 Global Finasteride Preparations Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Finasteride Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Finasteride Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Finasteride Preparations Tier 1, Tier 2, and Tier 3
4 Finasteride Preparations Market by Type
  1. 4.1 Finasteride Preparations Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Tablets
  4. 4.2 Global Finasteride Preparations Sales by Type
  5. 4.2.1 Global Finasteride Preparations Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Finasteride Preparations Sales by Type (2021-2032)
  7. 4.2.3 Global Finasteride Preparations Sales Market Share by Type (2021-2032)
  8. 4.3 Global Finasteride Preparations Revenue by Type
  9. 4.3.1 Global Finasteride Preparations Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Finasteride Preparations Revenue by Type (2021-2032)
  11. 4.3.3 Global Finasteride Preparations Revenue Market Share by Type (2021-2032)
5 Finasteride Preparations Market by Application
  1. 5.1 Finasteride Preparations Application Introduction
  2. 5.1.1 Male Pattern Baldness
  3. 5.1.2 Benign Prostatic Hyperplasia (BPH)
  4. 5.1.3 Other
  5. 5.2 Global Finasteride Preparations Sales by Application
  6. 5.2.1 Global Finasteride Preparations Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Finasteride Preparations Sales by Application (2021-2032)
  8. 5.2.3 Global Finasteride Preparations Sales Market Share by Application (2021-2032)
  9. 5.3 Global Finasteride Preparations Revenue by Application
  10. 5.3.1 Global Finasteride Preparations Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Finasteride Preparations Revenue by Application (2021-2032)
  12. 5.3.3 Global Finasteride Preparations Revenue Market Share by Application (2021-2032)
6 Global Finasteride Preparations Sales by Region
  1. 6.1 Global Finasteride Preparations Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Finasteride Preparations Sales by Region (2021-2032)
  3. 6.2.1 Global Finasteride Preparations Sales by Region (2021-2026)
  4. 6.2.2 Global Finasteride Preparations Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Finasteride Preparations Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Finasteride Preparations Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Finasteride Preparations Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Finasteride Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Finasteride Preparations Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Finasteride Preparations Revenue by Region
  1. 7.1 Global Finasteride Preparations Revenue by Region
  2. 7.1.1 Global Finasteride Preparations Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Finasteride Preparations Revenue by Region (2021-2026)
  4. 7.1.3 Global Finasteride Preparations Revenue by Region (2027-2032)
  5. 7.1.4 Global Finasteride Preparations Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Finasteride Preparations Revenue (2021-2032)
  8. 7.2.2 North America Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Finasteride Preparations Revenue (2021-2032)
  11. 7.3.2 Europe Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Finasteride Preparations Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Finasteride Preparations Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Finasteride Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
  7. 8.2 Grand Pharmaceutical
  8. 8.2.1 Grand Pharmaceutical Company Information
  9. 8.2.2 Grand Pharmaceutical Business Overview
  10. 8.2.3 Grand Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grand Pharmaceutical Finasteride Preparations Product Portfolio
  12. 8.2.5 Grand Pharmaceutical Recent Developments
  13. 8.3 Topfond Pharmaceutical
  14. 8.3.1 Topfond Pharmaceutical Company Information
  15. 8.3.2 Topfond Pharmaceutical Business Overview
  16. 8.3.3 Topfond Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Topfond Pharmaceutical Finasteride Preparations Product Portfolio
  18. 8.3.5 Topfond Pharmaceutical Recent Developments
  19. 8.4 Shanghai Shyndec Pharmaceutical
  20. 8.4.1 Shanghai Shyndec Pharmaceutical Company Information
  21. 8.4.2 Shanghai Shyndec Pharmaceutical Business Overview
  22. 8.4.3 Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio
  24. 8.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
  25. 8.5 Humanwell Pharmaceutical
  26. 8.5.1 Humanwell Pharmaceutical Company Information
  27. 8.5.2 Humanwell Pharmaceutical Business Overview
  28. 8.5.3 Humanwell Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Humanwell Pharmaceutical Finasteride Preparations Product Portfolio
  30. 8.5.5 Humanwell Pharmaceutical Recent Developments
  31. 8.6 Zhejiang Conba Pharmaceutical
  32. 8.6.1 Zhejiang Conba Pharmaceutical Company Information
  33. 8.6.2 Zhejiang Conba Pharmaceutical Business Overview
  34. 8.6.3 Zhejiang Conba Pharmaceutical Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio
  36. 8.6.5 Zhejiang Conba Pharmaceutical Recent Developments
  37. 8.7 CR Double-Crane
  38. 8.7.1 CR Double-Crane Company Information
  39. 8.7.2 CR Double-Crane Business Overview
  40. 8.7.3 CR Double-Crane Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CR Double-Crane Finasteride Preparations Product Portfolio
  42. 8.7.5 CR Double-Crane Recent Developments
  43. 8.8 Zydus
  44. 8.8.1 Zydus Company Information
  45. 8.8.2 Zydus Business Overview
  46. 8.8.3 Zydus Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Finasteride Preparations Product Portfolio
  48. 8.8.5 Zydus Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Finasteride Preparations Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma Finasteride Preparations Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 Organon
  62. 8.11.1 Organon Company Information
  63. 8.11.2 Organon Business Overview
  64. 8.11.3 Organon Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Organon Finasteride Preparations Product Portfolio
  66. 8.11.5 Organon Recent Developments
  67. 8.12 Hetero
  68. 8.12.1 Hetero Company Information
  69. 8.12.2 Hetero Business Overview
  70. 8.12.3 Hetero Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hetero Finasteride Preparations Product Portfolio
  72. 8.12.5 Hetero Recent Developments
  73. 8.13 Dr. Reddy's Laboratories
  74. 8.13.1 Dr. Reddy's Laboratories Company Information
  75. 8.13.2 Dr. Reddy's Laboratories Business Overview
  76. 8.13.3 Dr. Reddy's Laboratories Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio
  78. 8.13.5 Dr. Reddy's Laboratories Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Finasteride Preparations Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Alkem
  86. 8.15.1 Alkem Company Information
  87. 8.15.2 Alkem Business Overview
  88. 8.15.3 Alkem Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alkem Finasteride Preparations Product Portfolio
  90. 8.15.5 Alkem Recent Developments
  91. 8.16 Accord Healthcare
  92. 8.16.1 Accord Healthcare Company Information
  93. 8.16.2 Accord Healthcare Business Overview
  94. 8.16.3 Accord Healthcare Finasteride Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Accord Healthcare Finasteride Preparations Product Portfolio
  96. 8.16.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Finasteride Preparations Value Chain Analysis
  2. 9.1.1 Finasteride Preparations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Finasteride Preparations Production Mode & Process
  6. 9.2 Finasteride Preparations Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Finasteride Preparations Distributors
  9. 9.2.3 Finasteride Preparations Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst